Internal Medicine, Endocrinology, Diabetes, & Metabolism · Birmingham, AL
NPI
1447273586
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
817 Princeton Ave. SW
Birmingham, AL, 35211
Phone (205) 787-2669
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,898 services
Medicare patients, 2024
319
Average age 73
Drug cost, 2024
$4.3M
10,001 prescriptions
Company payments, 2025
$1,845
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Malek S Karassi was code 99214 (office e&m - established), 487 times for 256 patients. In total Malek S Karassi billed 1,898 services in 20 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 487 | 256 | $74.17 | $36K |
| 95251 Test - Miscellaneous | Office | 364 | 166 | $20.87 | $7,598 |
| 83036 Blood Count | Office | 306 | 178 | $9.09 | $2,782 |
| 82947 Clinical Chemistry | Office | 109 | 78 | $3.71 | $405 |
| 99215 Office E&M - Established | Office | 97 | 63 | $103.36 | $10K |
| 99213 Office E&M - Established | Office | 71 | 61 | $45.94 | $3,262 |
| 95249 Test - Miscellaneous | Office | 67 | 52 | $37.61 | $2,520 |
| 99204 Office E&M - New | Office | 46 | 46 | $94.46 | $4,345 |
| 99205 Office E&M - New | Office | 20 | 20 | $128.57 | $2,571 |
| 76536 Ultrasound - Nonspecific | Office | 12 | 12 | $60.18 | $722 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $26.78 | $295 |
By year: 2022 $107K for 5,965 services; 2023 $113K for 5,337 services; 2024 $73K for 1,898 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 306 | 178 | $9.09 | $2,782 |
| 82947 Clinical Chemistry | 109 | 78 | $3.71 | $405 |
Medicare prescription drug claims, 2024
In 2024, the drug Malek S Karassi prescribed most often to Medicare patients was Levothyroxine Sodium, with 835 prescriptions and refills. In total Malek S Karassi wrote 10,001 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 835 | 2,388 | 277 | $10K |
| Ozempic Semaglutide | 762 | 1,283 | 190 | $1.2M |
| Metformin Hcl Er Metformin Hcl | 653 | 1,651 | 230 | $10K |
| Mounjaro Tirzepatide | 555 | 747 | 114 | $797K |
| Humalog Kwikpen U-100 Insulin Lispro | 419 | 713 | 167 | $87K |
| Metformin Hcl Generic | 378 | 967 | 132 | $3,615 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 347 | 629 | 155 | $36K |
| Jardiance Empagliflozin | 332 | 655 | 92 | $356K |
| Glimepiride Generic | 324 | 858 | 108 | $2,572 |
| Glipizide Generic | 282 | 672 | 88 | $2,433 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 204 | 335 | 79 | $36K |
| Humalog Insulin Lispro | 202 | 423 | 59 | $48K |
| Gabapentin Generic | 200 | 420 | 50 | $3,281 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 185 | 365 | 58 | $135K |
| Atorvastatin Calcium Generic | 171 | 487 | 57 | $2,391 |
Brand drugs: 5,339 claims; generic drugs: 4,006 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Malek S Karassi $1,845 ($1,845 in general payments such as food, travel and fees) from 21 companies. The largest payer was Lilly USA, LLC with $263.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 12 | $263 |
| Novo Nordisk Inc NVO | 14 | $244 |
| Abbott Laboratories ABT | 14 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $159 |
| Abbvie Inc. ABBV | 11 | $154 |
| Sanofi-Aventis U.S. LLC SNY | 7 | $127 |
| Tandem Diabetes Care, Inc. TNDM | 5 | $109 |
| Medtronic, Inc. MDT | 5 | $85.13 |
| Xeris Pharmaceuticals, Inc. | 4 | $80.1 |
| Corcept Therapeutics CORT | 4 | $75.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.